Глушители. Приборы бесшумной стрельбы



pulmonary abscess treatment :: Article Creator

Small Cell Lung Cancer Treatments

Treatment for limited-stage small cell lung cancer (SCLC) often aims to cure the cancer. Extensive-stage SCLC treatment usually aims to prolong your life and reduce your symptoms.

Small cell lung cancer (SCLC) makes up 10–15% of all lung cancers. It tends to spread quickly and has a poor outlook.

In the United States, people diagnosed with SCLC from 2012–2018 lived at least 5 years about 7% as often as people without SCLC.

It's important to note that a person's individual outlook depends on the stage of cancer when it's diagnosed and how it responds to treatment. As newer or improved treatments are available, survival rates may continue to increase.

Some of the most common treatments for SCLC include:

Doctors are also trying many new treatments in clinical trials to see if they're more effective than current options.

Read on to learn more about what types of treatments are used to treat SCLC and when these treatments might be recommended.

SCLC is usually divided into two types: limited-stage or extensive-stage. It's classified as extensive-stage if it has spread:

  • throughout your lung
  • to your other lung
  • to lymph nodes on the other side of your chest
  • About two-thirds of people have extensive-stage SCLC when they receive a diagnosis. Treatment for extensive-stage SCLC usually revolves around trying to extend your life and reduce symptoms.

    Treatment for limited-stage SCLC often aims to cure the cancer.

    Chemotherapy is used to treat limited- or extensive-stage SCLC, often in combination with other treatments. Chemotherapy drugs are usually given as an intravenous (IV) infusion or an injection. They're sometimes administered through larger IVs called central venous catheters.

    For limited-stage SCLC

    Treatment for limited-stage SCLC may include:

  • chemotherapy with or without radiation therapy to the chest
  • chemotherapy after surgery with or without radiation therapy
  • For extensive-stage SCLC

    Treatment for extensive-stage SCLC may include:

    Doctors often administer a combination of chemotherapy drugs to target cancer cells in different ways. Some of the most common combinations in people with SCLC include:

  • cisplatin and etoposide
  • carboplatin and etoposide
  • cisplatin and irinotecan
  • carboplatin and irinotecan
  • Learn more about how chemotherapy is used to treat SCLC.

    Immunotherapy medications stimulate your immune system to attack cancer cells. Doctors use a type of immunotherapy called immune checkpoint inhibitors to treat extensive-stage SCLC, often in combination with chemotherapy.

    Immune checkpoint inhibitors work by blocking proteins made by cancer cells that allow them to hide from your immune cells. In the case of SCLC, doctors administer atezolizumab or durvalumab to block the protein PD-L1.

    These drugs are usually given through an IV every 2–4 weeks.

    Learn more about immunotherapy for lung cancer.

    Radiation therapy is one of the most common treatments for SCLC. It involves aiming high energy rays at cancer cells to kill them. Doctors usually use external beam radiation therapy to treat lung cancer. This type of radiation therapy involves administering radiation from a machine outside of your body.

    For limited-stage SCLC

    Radiation therapy may be used to treat limited-stage SCLC:

  • in combination with chemotherapy
  • in combination with chemotherapy after surgery
  • as cranial irradiation to prevent the spread to your brain
  • For extensive-stage SCLC

    For extensive-stage disease, it may be administered:

  • to your chest if you respond to chemotherapy
  • to your brain, spine, bones, or other body parts as a palliative therapy
  • to your brain if you had a complete response to other treatments
  • Radiation as an initial SCLC treatment is usually given 1–2 times daily, 5 days per week for 3–7 weeks, according to the American Cancer Society (ACS). Cranial irradiation is usually administered for fewer than 3 weeks, the ACS says.

    Research from 2021 estimates that in 10–20% of people with SCLC, the cancer has spread (metastasized) to the brain by the time of diagnosis, while 50–80% eventually develop metastasis during treatment.

    Research from 2020 supports that cranial irradiation reduces the chances of cancer spreading to the brain, but it's less clear whether it improves survival.

    Learn more about radiation therapy for lung cancer.

    SCLC has usually spread too far to be treated surgically when it is diagnosed. Surgery may be used for limited-stage disease:

  • before chemotherapy
  • before chemotherapy in combination with radiation therapy
  • Surgery is usually performed under general anesthesia through a large incision in your back or chest. Doctors can use different types of surgery to treat lung cancer such as:

  • Pneumonectomy: This is a procedure where your entire lung is removed.
  • Lobectomy: This procedure to remove one of the lobes of your lung. Your right lung has three lobes and your left lung has two.
  • Sleeve resection: This is a procedure to treat tumors in large airways. It involves cutting above and below the tumor and reattaching the two ends of your airway.
  • Segmentectomy: This is a procedure to remove the part of a lobe that contains the tumor.
  • You may also have lymph nodes removed during any of these procedures.

    Learn more about types of surgery for lung cancer.

    Palliative procedures can help reduce your symptoms and increase your survival time. They don't aim to cure the cancer.

    Palliative procedures include:

  • radiation therapy to treat cancer that has spread to distant body parts
  • photodynamic therapy to improve your breathing, which involves injecting a light-activated drug into a vein
  • laser therapy to open blocked airways
  • stent placement to open up airways
  • treatments for fluid buildup around your lungs such as:
  • treatments for fluid buildup around the heart such as:
  • Learn more about the final stages of lung cancer.

    Researchers are continuing to examine new treatments for SCLC in clinical trials. These treatments will become the new standard treatments if researchers find they're more effective than current options.

    Some clinical trials currently underway include:

  • examining whether brain scans alone are as effective as brain scans with cranial irradiation for improving survival
  • examining whether the addition of radiation therapy to immune therapy improves survival of extensive-stage SCLC
  • examining the potential benefit of adding the drug BAY 1895344 to usual chemotherapy for advanced solid tumors (in particular, SCLC tumors)
  • examining the benefit of adding the immunotherapy drug atezolizumab to usual chemoradiation therapy
  • examining the drug tazemetostat combined with topotecan and pembrolizumab for recurrent SCLC
  • Learn more about clinical trials for SCLC.

    SCLC is an aggressive form of lung cancer. It has usually already spread beyond the lungs when it's diagnosed.

    Treatment for limited-stage SCLC often includes some combination of chemotherapy, surgery, and radiation therapy to try to cure the cancer.

    Extensive-stage disease is usually treated with a combination of chemotherapy, radiation therapy, and immunotherapy.


    September Is Pulmonary Fibrosis Awareness Month; What Is It?

    September is Pulmonary Fibrosis Awareness Month. The condition causes lung scarring over time, resulting in horrible symptoms and low oxygen levels. It blocks the movement of oxygen from the lungs to the bloodstream.

    Not too many people are familiar with the disease.

    There's no cure, or specific cause, for this.

    Cheri Riley of Greece was diagnosed in 2017. At the time, she had no idea what it was, and didn't even have symptoms.

    Now, she's educating the public about it, with hopes to help others and maybe even save lives.

    She enrolled in a clinical trial in January. It's her only hope for managing the disease, since the other two medications used to treat it don't work effectively on her body.

    Every day, for four times a day, Cheri takes 12 breaths from a blue, ultrasonic nebulizer.

    "My blue bong. It's easier to say 'I'm going to go hit my bong' than 'I have to do a treatment,'" she said, laughing.

    Symptoms include dry cough, breathlessness and fatigue. But Cheri actually didn't develop those until later on.

    "The disease has progressed to the point where I need to wear oxygen anytime I'm talking a lot, which I do a lot!" she said. "Or, if I'm out walking around, that exertion is too much. My lungs have scarred too much."

    She's never been a smoker, and said no other health conditions contributed to this. It just crept up on her.

    All it took was one doctor to listen closely during a routine check-up.

    "He just said, 'let me take a listen to your lungs.' And he kept going back to one spot, and he instantly changed his demeanor."

    Now she's raising awareness, because detection is hard. She said many people live with the disease and don't know it. Sometimes, doctors mistake it for other things.

    This month, Cheri is encouraging others to raise awareness by wearing blue.

    Buildings in Rochester were lit up blue over the weekend.

    "And I knew that Rochester would come through," she said.

    In the meantime, she's leaning into her support system, and enjoying her hobby of painting while retired.

    She says she'll continue to speak out, until her last breath.

    Cheri also spoke highly of her doctors at the University of Rochester Medical Center. The U of R said it is home to Upstate New York's only Pulmonary Fibrosis Foundation Care Center Network. A spokesperson said it's a prestigious designation among the top institutions across the country.

    Cheri also works as an ambassador for the Pulmonary Fibrosis Foundation.

    Two major support groups in Rochester support over 80 people.

    To find support, visit here.


    Lung Disease News

    July 25, 2023 — Having a food allergy as a baby is linked to asthma and reduced lung function later in childhood, according to a new ...

    July 20, 2023 — Omega-3 fatty acids, which are abundant in fish and fish oil supplements, appear promising for maintaining lung health, according to new evidence from a large, multi-faceted study in healthy adults. ...

    July 7, 2023 — The mucus in the airways is not as sticky, inflammation in the lungs significantly reduced: Triple combination therapy can achieve these positive, lasting effects in patients with cystic fibrosis ...

    June 22, 2023 — Small-cell lung cancer is a particularly aggressive type of tumor with a consistently high mortality rate. In recent years, the research of scientists has significantly contributed to a better ...

    June 8, 2023 — The largest and most comprehensive cell map of the human lung has been completed. The Human Lung Cell Atlas reveals the great diversity of cell types in the lung and shows key differences between ...

    June 1, 2023 — Researchers have collaborated to refine a cell culture technology platform that grows genetically identical lung buds from human embryonic stem ...

    May 24, 2023 — A new study has shown that human T cells have an important role to play in controlling ...

    Apr. 21, 2023 — Storing donor lungs for transplant at 10 degrees Celsius markedly increases the length of time the organ can live outside the body according to new ...

    Mar. 31, 2023 — A new type of nanoparticle can be administered to the lungs, where it can deliver messenger RNA encoding useful proteins. Researchers hope to use them to develop new treatments for cystic fibrosis ...

    Mar. 28, 2023 — Researchers develop a 3D cell culture system to test how inhibiting fibroblast activities can help treat lung cancer. To simulate the tumor microenvironment and mimic real tissues, the team ...

    Mar. 17, 2023 — A new study has revealed FDA-approved trametinib and entinostat (which is currently in clinical trials) can be given in tandem to produce fewer and smaller tumors in mice with LKB1-mutated non-small ...

    Mar. 15, 2023 — A new study represents a first step towards generating highly detailed 3-dimensional maps of lung tumors using genetically engineered mouse ...

    Mar. 13, 2023 — Scientists have discovered why breast cancer cells that have spread to the lungs may 'wake up' following years of sleep -- forming incurable secondary tumors. Their research reveals the ...

    Mar. 10, 2023 — One in 10 adults suffer from the debilitating effects of chronic obstructive pulmonary disease (COPD). Research around a new breathing device developed by pulmonologists offers promise for improving ...

    Mar. 9, 2023 — Congenital diaphragmatic hernia is one of the deadliest birth defects. To better understand and treat this condition in the future, researchers designed a new cell model in the laboratory and tested ...

    Mar. 8, 2023 — Contracting a lower respiratory tract infection in early childhood is associated with a higher risk of dying from respiratory disease as an adult, according to new ...

    Feb. 27, 2023 — New research reveals how the relationship between nerves and immune cells in the lungs can contribute to the development of allergic ...

    Feb. 23, 2023 — As air pollution in Stockholm has decreased, so has the lung capacity of children and adolescents has improved, a new study reports. The researchers consider the results important, since the lung ...

    Feb. 22, 2023 — A new study uncovers how a protein, APOBEC3B, could protects cells against many different types of RNA viruses like respiratory syncytial virus (RSV), SARS-CoV2, influenza virus, poliovirus and ...

    Feb. 8, 2023 — A new study reveals how resistance to bacteraemic pneumonia is provided by a unique subset of lung T regulatory ...

    Tuesday, July 25, 2023

    Thursday, July 20, 2023

    Friday, July 7, 2023

    Thursday, June 22, 2023

    Thursday, June 8, 2023

    Thursday, June 1, 2023

    Wednesday, May 24, 2023

    Friday, April 21, 2023

    Friday, March 31, 2023

    Tuesday, March 28, 2023

    Friday, March 17, 2023

    Wednesday, March 15, 2023

    Monday, March 13, 2023

    Friday, March 10, 2023

    Thursday, March 9, 2023

    Wednesday, March 8, 2023

    Monday, February 27, 2023

    Thursday, February 23, 2023

    Wednesday, February 22, 2023

    Wednesday, February 8, 2023

    Wednesday, February 1, 2023

    Thursday, January 19, 2023

    Thursday, January 12, 2023

    Monday, January 9, 2023

    Thursday, January 5, 2023

    Wednesday, January 4, 2023

    Wednesday, December 28, 2022

    Monday, December 26, 2022

    Thursday, December 22, 2022

    Wednesday, December 21, 2022

    Tuesday, December 6, 2022

    Monday, December 5, 2022

    Friday, December 2, 2022

    Thursday, December 1, 2022

    Wednesday, November 30, 2022

    Tuesday, November 29, 2022

    Tuesday, November 22, 2022

    Monday, November 21, 2022

    Thursday, November 17, 2022

    Wednesday, November 16, 2022

    Tuesday, November 15, 2022

    Tuesday, November 8, 2022

    Thursday, November 3, 2022

    Wednesday, November 2, 2022

    Wednesday, October 26, 2022

    Tuesday, October 25, 2022

    Monday, October 17, 2022

    Monday, October 10, 2022

    Tuesday, October 4, 2022

    Tuesday, September 27, 2022

    Friday, September 23, 2022

    Thursday, September 22, 2022

    Monday, September 19, 2022

    Friday, September 16, 2022

    Thursday, September 15, 2022

    Wednesday, September 14, 2022

    Tuesday, September 13, 2022

    Thursday, September 8, 2022

    Tuesday, September 6, 2022

    Monday, September 5, 2022

    Friday, September 2, 2022

    Thursday, September 1, 2022

    Wednesday, August 31, 2022

    Thursday, August 25, 2022

    Thursday, August 18, 2022

    Tuesday, August 9, 2022

    Monday, August 8, 2022

    Tuesday, August 2, 2022

    Monday, August 1, 2022

    Thursday, July 28, 2022

    Wednesday, July 27, 2022

    Tuesday, July 26, 2022

    Monday, July 25, 2022

    Wednesday, July 20, 2022

    Monday, July 18, 2022

    Thursday, July 14, 2022

    Tuesday, July 5, 2022

    Wednesday, June 29, 2022

    Thursday, June 23, 2022

    Tuesday, June 21, 2022

    Tuesday, June 14, 2022

    Friday, June 10, 2022

    Thursday, June 9, 2022

    Friday, June 3, 2022

    Thursday, June 2, 2022

    Tuesday, May 24, 2022






    Comments

    Popular posts from this blog

    Epoprostenol Via High-Flow Nasal Cannula Improves Severe Hypoxemia in PH - Pulmonology Advisor

    Novitium's Generic Sildenafil for PAH Treatment Approved by FDA - Pulmonary Hypertension News

    Analysis: Large pharma companies do little new drug innovation - STAT